JPS52143218A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
JPS52143218A
JPS52143218A JP3022277A JP3022277A JPS52143218A JP S52143218 A JPS52143218 A JP S52143218A JP 3022277 A JP3022277 A JP 3022277A JP 3022277 A JP3022277 A JP 3022277A JP S52143218 A JPS52143218 A JP S52143218A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3022277A
Other languages
English (en)
Inventor
Toomasu Deinguru Jiyon
Roorii Goodon Jiyon
Jiyoonzu Jiereinto
Gurahamu Naito Kuraibu
Saundaasu Roui Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
National Research Development Corp UK
Original Assignee
Imperial Chemical Industries Ltd
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, National Research Development Corp UK filed Critical Imperial Chemical Industries Ltd
Publication of JPS52143218A publication Critical patent/JPS52143218A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3022277A 1976-03-19 1977-03-18 Pharmaceutical composition Pending JPS52143218A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11147/76A GB1523965A (en) 1976-03-19 1976-03-19 Pharmaceutical compositions containing steroids

Publications (1)

Publication Number Publication Date
JPS52143218A true JPS52143218A (en) 1977-11-29

Family

ID=9980901

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3022377A Pending JPS52114026A (en) 1976-03-19 1977-03-18 Pharmaceutical composition having antiiinflammation activity
JP3022277A Pending JPS52143218A (en) 1976-03-19 1977-03-18 Pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP3022377A Pending JPS52114026A (en) 1976-03-19 1977-03-18 Pharmaceutical composition having antiiinflammation activity

Country Status (13)

Country Link
US (1) US4427649A (ja)
JP (2) JPS52114026A (ja)
AU (1) AU509606B2 (ja)
BE (2) BE852444A (ja)
CA (1) CA1075156A (ja)
DE (2) DE2712030C2 (ja)
FR (2) FR2344290A1 (ja)
GB (1) GB1523965A (ja)
IE (1) IE44865B1 (ja)
IL (1) IL51568A (ja)
NL (2) NL7702955A (ja)
NZ (1) NZ183411A (ja)
ZA (2) ZA771091B (ja)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55141407A (en) * 1979-04-11 1980-11-05 Nattermann A & Cie Nonoral administration solution containing arylacetic acid or arylpropionic acid derivative
JPS56161317A (en) * 1980-05-15 1981-12-11 Green Cross Corp:The Pharmaceutical preparation of fatty corpuscle of steroid
JPS57112334A (en) * 1979-12-27 1982-07-13 Fumaan Orutooaniyuaguterumeree Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture
JPS58152812A (ja) * 1982-02-17 1983-09-10 チバ−ガイギ−・アクチエンゲゼルシヤフト 水性相中単層脂質顆粒の製造方法
JPS58201712A (ja) * 1982-05-18 1983-11-24 Green Cross Corp:The 脂肪乳剤
JPS6143110A (ja) * 1984-07-30 1986-03-01 アクチエボラゲツト・ドラコ ステロイドエステルを含有するリポソーム
US6710038B1 (en) 1999-12-14 2004-03-23 Kibun Food Chemifa Co., Ltd. Emulsification method using propylene glycol hyaluronate
JP2008542438A (ja) * 2005-06-09 2008-11-27 バイオリポックス エービー 炎症性疾患の治療のための方法及び組成物
JP2009507009A (ja) * 2005-09-01 2009-02-19 バイオリポックス エービー 抗ヒスタミン剤及びコルチコステロイド含有リポソーム組成物と鼻炎及びその関連疾患を治療するための医薬の製造のためのその使用

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1116518A (en) * 1977-09-30 1982-01-19 Guido Neri Method for purifying a liposomic suspension
IT1111367B (it) * 1978-11-17 1986-01-13 Serono Ist Farm Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
DE2914789A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Injizierbare arzneimittel mit entzuendungshemmender wirkung
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
EP0072936B1 (de) * 1981-08-12 1985-12-18 A. Nattermann & Cie. GmbH Neue O-alkyl-O-carbamoyl-glycero-phosphocholine und Verfahren zu ihrer Herstellung
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
MX9203290A (es) * 1983-09-19 1992-08-01 Liposome Co Inc Suministro localizado usando conjugados de fibronectina.
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4921706A (en) * 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
US5622713A (en) * 1985-09-17 1997-04-22 The Regents Of The University Of California Method of detoxifying animal suffering from overdose
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
EP0244405B1 (en) * 1985-10-31 1991-10-23 Kv Pharmaceutical Company Vaginal delivery systems
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
DE3683606D1 (de) * 1985-11-27 1992-03-05 Ethicon Inc Hemmung der postoperativen adhaesionsbildung durch topische verabreichung eines entzuendungshemmenden nichtsteroiden wirkstoffs.
IN166447B (ja) * 1985-11-27 1990-05-12 Ethicon Inc
DE3542773A1 (de) * 1985-12-04 1987-06-11 Roehm Pharma Gmbh Hautwirksame pharmaka mit liposomen als wirkstofftraeger
EP0234897A3 (en) * 1986-02-24 1987-11-19 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the continual topical administration of glucocorticoid
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
US6759057B1 (en) 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU7543887A (en) * 1986-06-12 1988-01-11 Liposome Company, Inc., The Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
US5202126A (en) * 1987-08-20 1993-04-13 Parfums Christian Dior Composition containing pregnenolone or a pregnenolone ester incorporated in liposomes, and a method for regenerating, or revitalizing the skin therewith
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
US4915951A (en) * 1987-12-03 1990-04-10 California Institute Of Technology Cryoprotective reagent
GB2217596A (en) * 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
ATE145337T1 (de) * 1988-05-02 1996-12-15 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
FR2637182B1 (fr) * 1988-10-03 1992-11-06 Lvmh Rech Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant
US5015483A (en) * 1989-02-09 1991-05-14 Nabisco Brands, Inc. Liposome composition for the stabilization of oxidizable substances
US5139803A (en) * 1989-02-09 1992-08-18 Nabisco, Inc. Method and liposome composition for the stabilization of oxidizable substances
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6088613A (en) * 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US6001335A (en) * 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US20020150539A1 (en) * 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
DE4108902A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Wasserhaltiges liposomensystem
EP0560900B1 (en) * 1990-12-03 1995-02-08 Vestar, Inc. Prevention of synovial adhesions
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5874062A (en) * 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
CA2124329C (en) * 1991-11-27 2008-11-18 Gregory A. Kopia Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
ATE192327T1 (de) * 1993-03-24 2000-05-15 Collaborative Lab Inc Kosmetisches verabreichungssystem für salizylsäure und verfahren zur herstellung desselben
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5997898A (en) * 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US20040208922A1 (en) * 1995-06-07 2004-10-21 The Regents Of The University Of California Method for loading lipid like vesicles with drugs or other chemicals
US6521211B1 (en) * 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
WO1997014407A1 (en) * 1995-10-17 1997-04-24 Research Triangle Pharmaceuticals Insoluble drug delivery
CA2252617A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
DK1323434T3 (da) * 1996-09-11 2007-11-12 Bristol Myers Squibb Medical I Fremgangsmåde til diagnostisk billeddannelse af nyreregioner under anvendelse af et kontrastmiddel og en vasodilator
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US5827532A (en) * 1997-01-31 1998-10-27 The Reagents Of The University Of California Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
US6537246B1 (en) * 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US20050019266A1 (en) * 1997-05-06 2005-01-27 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) * 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE69908304T2 (de) * 1998-02-11 2004-02-19 Rtp Pharma Corp. Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP1079808B1 (en) 1998-05-29 2004-02-11 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
DK1105096T3 (da) 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
EP1214059B1 (en) * 1999-09-21 2005-05-25 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
DK1955700T3 (da) 1999-09-30 2011-05-23 Harbor Biosciences Inc Terapeutisk behandling af androgenreceptor-betingede lidelser
CA2407027C (en) 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
CU23175A1 (es) * 2000-07-17 2006-09-22 Ct De Investigacion Y Desarrol Formulacion liposomica de propionato de clobetasol
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
AU2001255515A1 (en) * 2000-09-20 2002-04-02 Skyepharma Canada Inc. Stabilised fibrate microparticles
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
NZ527408A (en) * 2001-02-22 2005-04-29 Skyepharma Canada Inc Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
CA2439687A1 (en) 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Use of certain steroids for treatment of blood cell deficiencies
FR2827765B1 (fr) * 2001-07-27 2003-09-19 Oreal Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea
WO2003090681A2 (en) * 2002-04-24 2003-11-06 Research Development Foundation SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-κB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
WO2004000229A2 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
AU2003265576A1 (en) * 2002-08-23 2004-03-11 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
WO2005011633A1 (ja) * 2003-08-01 2005-02-10 National Institute Of Advanced Industrial Science And Technology 標的指向性リポソームを含む炎症性疾患治療薬または診断薬
WO2005020958A2 (en) * 2003-08-26 2005-03-10 Research Development Foundation Aerosol delivery of curcumin
WO2006046934A2 (en) 2003-08-26 2006-05-04 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
WO2005034915A2 (en) * 2003-10-03 2005-04-21 Alza Corporation Screening method for evaluation of bilayer-drug interaction in liposomal compositions
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
CA2582231A1 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Steroid analogs and uses
CA2697160A1 (en) * 2007-08-21 2009-02-26 Harbor Biosciences, Inc. Stabilized therapeutic compositions and formulations
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US20130209550A1 (en) 2010-07-28 2013-08-15 Life Technologies Corporation Anti-Viral Azide Containing Compounds
CN108977412A (zh) 2012-01-26 2018-12-11 生命科技公司 用于提高病毒感染性的方法
US20150125438A1 (en) * 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
AU2014235854B2 (en) 2013-03-21 2019-04-11 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
ES2672993T3 (es) 2015-10-27 2018-06-19 Eupraxia Pharmaceuticals Inc. Formulaciones de liberación sostenida de anestésicos locales
CN105732756B (zh) * 2016-01-29 2017-11-03 首都师范大学 一种脂溶性地塞米松衍生物的纯化方法
US10836788B2 (en) 2019-02-05 2020-11-17 SD Chem, Inc. Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (de) 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
CH588887A5 (ja) * 1974-07-19 1977-06-15 Battelle Memorial Institute

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55141407A (en) * 1979-04-11 1980-11-05 Nattermann A & Cie Nonoral administration solution containing arylacetic acid or arylpropionic acid derivative
JPH0337524B2 (ja) * 1979-04-11 1991-06-05 Nattermann A & Cie
JPH0314814B2 (ja) * 1979-12-27 1991-02-27 Fumaan Orutooanyuaguterumeree Eeshu Kutatoo Inteezeto
JPS57112334A (en) * 1979-12-27 1982-07-13 Fumaan Orutooaniyuaguterumeree Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture
JPS56161317A (en) * 1980-05-15 1981-12-11 Green Cross Corp:The Pharmaceutical preparation of fatty corpuscle of steroid
JPH0379059B2 (ja) * 1982-02-17 1991-12-17 Ciba Geigy
JPS58152812A (ja) * 1982-02-17 1983-09-10 チバ−ガイギ−・アクチエンゲゼルシヤフト 水性相中単層脂質顆粒の製造方法
JPH0247446B2 (ja) * 1982-05-18 1990-10-19 Midori Juji Kk
JPS58201712A (ja) * 1982-05-18 1983-11-24 Green Cross Corp:The 脂肪乳剤
JPS6143110A (ja) * 1984-07-30 1986-03-01 アクチエボラゲツト・ドラコ ステロイドエステルを含有するリポソーム
JPH0459297B2 (ja) * 1984-07-30 1992-09-21 Draco Ab
US6710038B1 (en) 1999-12-14 2004-03-23 Kibun Food Chemifa Co., Ltd. Emulsification method using propylene glycol hyaluronate
JP2008542438A (ja) * 2005-06-09 2008-11-27 バイオリポックス エービー 炎症性疾患の治療のための方法及び組成物
JP2013209423A (ja) * 2005-06-09 2013-10-10 Meda Ab 炎症性疾患の治療のための方法及び組成物
JP2009507009A (ja) * 2005-09-01 2009-02-19 バイオリポックス エービー 抗ヒスタミン剤及びコルチコステロイド含有リポソーム組成物と鼻炎及びその関連疾患を治療するための医薬の製造のためのその使用

Also Published As

Publication number Publication date
NL7702955A (nl) 1977-09-21
DE2712030A1 (de) 1977-09-29
JPS52114026A (en) 1977-09-24
CA1075156A (en) 1980-04-08
GB1523965A (en) 1978-09-06
IE44865B1 (en) 1982-04-21
NL7702954A (nl) 1977-09-21
AU2268077A (en) 1978-08-31
ZA771090B (en) 1978-01-25
FR2344287A1 (fr) 1977-10-14
FR2344287B1 (ja) 1980-06-27
IL51568A (en) 1979-11-30
DE2712030C2 (de) 1985-10-03
BE852445A (fr) 1977-09-14
ZA771091B (en) 1978-01-25
BE852444A (fr) 1977-09-14
DE2712031A1 (de) 1977-09-29
US4427649A (en) 1984-01-24
AU509606B2 (en) 1980-05-15
FR2344290A1 (fr) 1977-10-14
IE44865L (en) 1977-09-19
NZ183411A (en) 1978-12-18

Similar Documents

Publication Publication Date Title
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
ZA774920B (en) Pharmaceutical compositions
JPS5362838A (en) Pharmaceutical composition
AU515341B2 (en) Pharmaceutical composition
PT66622B (en) Pharmaceutical compositions
JPS5372814A (en) Pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
AU3152677A (en) Pharmaceutical composition
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
NZ186147A (en) Sterolin pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
JPS5356634A (en) Pharmaceutical composition
AU2649977A (en) Pharmaceutical composition
AU508191B2 (en) Pharmaceutical composition
ZA772612B (en) Pharmaceutical compositions
HK69380A (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
JPS5283918A (en) Pharmaceutical composition
HK3984A (en) Pharmaceutical compositions
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions
ZA771408B (en) Pharmaceutical compositions
JPS52122633A (en) Pharmaceutical composition
ZA777335B (en) Pharmaceutical compounds
ZM3777A1 (en) Pharmaceutical composition